title

This special series of expert commentaries is part of a collaboration between Children's Hospital of Philadelphia (CHOP) and Medscape and is designed to provide practicing clinicians with updates and analysis on a range of clinically important topics from specialists affiliated with this world-famous pediatric facility.

Latest Features from CHOP

 

Offit on Vaccines

  • Paul A. Offit, MDPaul A. Offit, MD, Director, Vaccine Education Center and Attending Physician, Division of Infectious Diseases, The Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania and Professor, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. Paul Offit is the co-inventor of the RotaTeq® vaccine, but he receives no financial remuneration for sales of the vaccine from either the manufacturer or his employing institution
     
  • Stories of Science Gone Wrong: Paul Offit on His New Book Looking back at history, how many scientific inventions end up doing more harm than good? In a new book, Paul Offit, MD, tells readers seven stories about when scientists got things very wrong.
  • Fading Immunity May Be Behind Mumps Epidemic   Dr Paul Offit discusses potential weaknesses in the MMR vaccine, and ongoing efforts to address them.
  • If Children Got the HPV4 Vaccine Series, Should They Get HPV9?   Dr Paul Offit explains why those who have completed the HPV4 series should also receive HPV9.
  • The HPV Vaccine and Autoimmunity: Reviewing the Research Paul Offit reviews the evidence to respond to reader concerns about autoimmune conditions and the HPV vaccine.
  • The Rise and Fall of FluMist--Can This Spray Vaccine Be Redeemed?   Paul Offit explains why ACIP withdrew its recommendation to use FluMist preferentially to immunize children against influenza.
  • Should We Bring Back the Whole-Cell Pertussis Vaccine?   Priming with whole-cell and then finishing with acellular pertussis vaccine would better protect children from pertussis, says Paul Offit.